The keynote speaker for this webinar was Dr Samir Agrawal, who is a Senior Lecturer in Haematology at the Queen Mary University of London and a Consultant Haemato-Oncologist at St Bartholomew’s Hospitals and The Barts Health NHS Trust, London. Dr Agrawal discussed current developments in CLL treatment and research as well as CLL during the current Covid-19 restrictions.